Non-profit pharmaceutical companies have been granted priority reviews by the Food and Drug Administration for their over-the-counter opioid addiction treatment. This
is in response to the United States’ opioid epidemic.
Continue reading…
FDA grants priority review to over-the-counter opioid-overdose drug
